LB Bohle – 10.06.2025
Nipro Vialex – 26th January 2025
PCI – 7th June 2024
Temax_Krautz

Current Edition

Drug Discovery 2025, ELRIG – 04.07.2025
DDL 2025
Novo Nordisk 20 March 2024, 11:21
Carterra – 24th March 2025
HCMed
STEVANATO GROUP

STEVANATO GROUP

Founded in 1949, Stevanato Group is the world’s largest, privately owned designer and producer of glass packaging for the pharmaceutical industry. It is committed to create systems, processes and services that guarantee the integrity of parenteral medicines, a key contribution to the overall improvement of the pharmaceutical industry.
It comprises two operational divisions:

  • Pharmaceutical Systems:
    Ompi
    specialized in ready-to-use glass containers and bulk primary packaging, from syringes and cartridges to vials and ampoules. It is well positioned to serve the future needs of its clients with production sites located throughout Europe (Piombino Dese-Padua and Latina in Italy, Bratislava in Slovakia), in Monterrey, Mexico that is supported by a commercial office in the USA, a greenfield facility in Zhangjiagang, China and a new plant under construction in Sete Lagoas, Brazil.Balda is a specialist for plastics solutions. It provides life cycle competence from product design, development, industrialization, regulatory approvals, series production, global supply chain management up to continuous improvement programs. Balda´s core technologies are multi-component precision injection molding, automated system assembly, surface decoration as well as tool making for the pharmaceuticals, diagnostic and medical technology sectors.
  • Engineering Systems with Spami, Optrel, InnoScan and SVM, specialized in glass processing, inspection systems, assembly, serialization and packaging solutions.

These two divisions enjoy a close, synchronous relationship, featuring daily exchanges, which ensure that Stevanato Group has complete control over the entire production process. The continual innovation and pioneering of new trends ensure the world most advanced solutions year after year, that can be guaranteed to patients and always seeking to exceed customer expectations.

The Group also benefits from the SGLab activity that provides technical and analytical services on the potential interaction between drug and container.

 

http://www.stevanatogroup.com/  
 

http://www.ompipharma.com/ 
 

http://www.balda-group.com/
 

Scott Pharma – 25.03.2025
Bespak – 21.05.2025
Woolcool 26 March 2024, 16:16
Biopharma group 6 March 2024, 09:40
EyeC 18 March 2024, 13:10
Nipro – 09.06.2025
Stoelzle – 15th May 2025
L.B. Bohle – 08.04.2025